Drug intelligence / Profile preview

acyline + testosterone enanthate

Development stage
Unknown
Lead developer
Merrion Pharmaceuticals
Modality
Peptides, Small Molecules
Administration
Subcutaneous, Intramuscular
01

Overview

Acyline + testosterone enanthate is an experimental combination therapy investigated primarily for male hormonal contraception. Acyline is a potent gonadotropin-releasing hormone (GnRH) antagonist that suppresses the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased endogenous testosterone production and inhibition of spermatogenesis[8][9]. Testosterone enanthate is a long-acting esterified form of testosterone, administered by injection, which acts as an agonist at the androgen receptor to maintain physiological androgen levels during suppression of endogenous production[5][6]. The combination aims to achieve effective suppression of sperm production while maintaining secondary sexual characteristics and minimizing side effects associated with low androgen levels. This regimen has been studied in small clinical trials for its potential as a reversible male contraceptive[4][9].

02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)AR (Adrenergic receptors)

Beyond the preview

Go deeper on acyline + testosterone enanthate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acyline + testosterone enanthate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call